Mary Malloy, MD

Co-director of the Adult Lipid Clinic
Director of the Pediatric Lipid Clinic

Dr. Mary Malloy, is co-director of the Adult Lipid Clinic and the director of the Pediatric Lipid Clinic, which she established in 1971. She is a graduate of the UCSF School of Medicine. She completed her internship, residency and a fellowship in pediatrics at the University of Washington and UCSF. She is a professor emeritus of medicine and pediatrics; and is a senior investigator in the Cardiovascular Research Institute. She has published widely on her research and clinical experience in journals and book chapters. Malloy's research interests have included lipoprotein metabolism, management of disorders of lipoproteins and the genetic bases of heart disease and stroke. She is a fellow of the American Heart Association and a diplomate of the American Board of Clinical Lipidology. She is consulted by physicians in the U.S. and abroad for help with diagnosis and management of complex cases involving lipoprotein disorders in children.

Clinics

Endocrinology Clinic at Parnassus
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8:30 a.m. – 5 pm.

Lipid Practice
400 Parnassus Ave., Suite A-550
San Francisco, CA 94143
Phone: (415) 353–2350
Fax: (415) 353–2337

Hours: Monday to Friday, 8:30 a.m. – 5 p.m.

Academic Title

Professor

More about Mary Malloy

Education

UCSF Medical School 1962

Residencies

University of Washington and UCSF Medical Center, Pediatrics 1965

Fellowships

UCSF Medical Center, Pediatrics 1966

Selected Research and Publications

  1. Wang C, Najm R, Xu Q, Jeong DE, Walker D, Balestra ME, Yoon SY, Yuan H, Li G, Miller ZA, Miller BL, Malloy MJ, Huang Y. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018 Apr 09.
  2. Kane J, Schaefer E, Malloy M. Xenosterolemia: emerging molecular and clinical insights. Curr Opin Lipidol. 2017 Dec; 28(6):518-519.
  3. Stock EO, Ferrara CT, O'Connor PM, Naya-Vigne JM, Frost PH, Malloy MJ, Kane JP, Pullinger CR. Levels of prebeta-1 high-density lipoprotein are elevated in 3 phenotypes of dyslipidemia. J Clin Lipidol. 2018 Jan - Feb; 12(1):99-109.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.